Shields is a renowned leader in the use of molecular imaging with PET/CT, and highly regarded for her expertise in the radionuclide treatment of various cancers.
Tag: prostate cancer
UVA offers an updated, more conformal version of the recommended combination therapy, which includes high-dose rate brachytherapy, intensity-modulated radiation therapy and use of a prostate-rectal spacer.
New ACR Appropriateness Criteria added unprecedented depth to what had been a much more modest overview, providing physicians an easy way to catch up with the latest developments and stay at the very forefront of best practices.
One of the most widely read stories among radiation oncologists this year is one announcing a prostate cancer discovery by UVA radiation oncologist Timothy Showalter, MD.